18F-labelled annexin V: a PET tracer for apoptosis imaging

Annexin V can be used to detect apoptotic cells in vitro and in vivo, based on its ability to identify extracellular phosphatidylserine, which arises during apoptosis. In the present study, we examined the synthesis of fluorine-18 labelled annexin V as a positron emission tomography tracer for apoptosis imaging. The distribution of [18F]annexin V and technetium-99m labelled annexin V, a well-characterised SPET tracer for apoptosis imaging, was compared. [18F]annexin V was synthesised using N-succinimidyl 4-[18F]fluorobenzoate as an 18F labelling reagent. Synthesised and purified [18F]annexin V was confirmed by SDS-PAGE. In an ex vivo imaging experiment, [18F]annexin V was intravenously injected into rats 24 h after the induction of myocardial ischaemia, and accumulation in the left ventricle was examined. [18F]annexin V accumulated in the infarct area of the left ventricle, where apoptotic cells were observed. In separate experiments, [18F]annexin V or [99mTc]annexin V was intravenously injected into ischaemic or normal animals, and the distribution of the tracers was compared. In ischaemic animals, accumulation of [18F]annexin V and [99mTc]annexin V in the infarct area was about threefold higher than in the non-infarct area. Furthermore, the ratio of accumulation in the normal heart to the blood radioactivity was not significantly different between the tracers. In normal animals, however, the uptake of [18F]annexin V in the liver, spleen and kidney was much lower than that of [99mTc]annexin V. The low uptake of [18F]annexin V in these organs might represent an advantage over [99mTc]annexin V.

[1]  A. Fischman,et al.  The use of pentafluorophenyl derivatives for the 18F labelling of proteins. , 1994, Nuclear medicine and biology.

[2]  J. Tait,et al.  Binding of annexin V/placental anticoagulant protein I to platelets. Evidence for phosphatidylserine exposure in the procoagulant response of activated platelets. , 1990, The Journal of biological chemistry.

[3]  G.,et al.  Annexin V for Flow Cytometric Detection of Phosphatidylserine Expression on B Cells Undergoing Apoptosis , 2000 .

[4]  W. Bernauer.  The effect of β-adrenoceptor blocking agents on evolving myocardial necrosis in coronary ligated rats with and without reperfusion , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[5]  G. L. Watkins,et al.  Aryltrimethylammonium trifluoromethanesulfonates as precursors to aryl [18F]fluorides: Improved synthesis of [18F]GBR‐13119 , 1989 .

[6]  G. Berry,et al.  The use of technetium Tc 99m annexin V for in vivo imaging of apoptosis during cardiac allograft rejection. , 1998, The Journal of thoracic and cardiovascular surgery.

[7]  W. Eckelman,et al.  One-step synthesis of 18F labeled [18F]-N-succinimidyl 4-(fluoromethyl)benzoate for protein labeling. , 1994, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[8]  M. Zalutsky,et al.  Labeling proteins with fluorine-18 using N-succinimidyl 4-[18F]fluorobenzoate. , 1992, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[9]  V. Fadok,et al.  Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. , 1992, Journal of immunology.

[10]  K. Jacobson,et al.  18F-labeled insulin: a prosthetic group methodology for incorporation of a positron emitter into peptides and proteins. , 1989, Biochemistry.

[11]  R. Davis,et al.  In vivo detection and imaging of phosphatidylserine expression during programmed cell death. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[12]  H. Pollard,et al.  Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. , 1994, Biochimica et biophysica acta.

[13]  A Pierangeli,et al.  Protective effect of low frequency low energy pulsing electromagnetic fields on acute experimental myocardial infarcts in rats. , 1999, Bioelectromagnetics.

[14]  G. Berry,et al.  Radionuclide imaging of acute lung transplant rejection with annexin V. , 2000, Chest.

[15]  P. Doevendans,et al.  Visualisation of cell death in vivo in patients with acute myocardial infarction , 2000, The Lancet.

[16]  C. Ling,et al.  Iodination of annexin V for imaging apoptosis. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  K. Fujikawa,et al.  Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family. , 1989, The Journal of biological chemistry.

[18]  H C Hemker,et al.  Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. , 1990, The Journal of biological chemistry.

[19]  R. Davis,et al.  Imaging of apoptosis (programmed cell death) with 99mTc annexin V. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  H. Coenen,et al.  Fluoroacylation agents based on small n.c.a. [18F]fluorocarboxylic acids , 1994 .

[21]  R. Kitsis,et al.  Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53. , 1997, The Journal of clinical investigation.

[22]  D. Green,et al.  Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl , 1995, The Journal of experimental medicine.

[23]  H. Wellens,et al.  Cardiomyocyte Death Induced by Myocardial Ischemia and Reperfusion: Measurement With Recombinant Human Annexin-V in a Mouse Model , 2000, Circulation.

[24]  HenryFliss,et al.  Apoptosis in Ischemic and Reperfused Rat Myocardium , 1996 .

[25]  F. Blankenberg,et al.  Development and characterization of annexin V mutants with endogenous chelation sites for (99m)Tc. , 2000, Bioconjugate chemistry.

[26]  Roland Hustinx,et al.  Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[27]  K. Hamacher,et al.  A comparative study of N.C.A. fluorine-18 labeling of proteins via acylation and photochemical conjugation. , 1996, Nuclear medicine and biology.

[28]  K. Hashimoto,et al.  Effects and interaction, of cariporide and preconditioning on cardiac arrhythmias and infarction in rat in vivo , 1999, British journal of pharmacology.

[29]  P. Garg,et al.  Fluorine-18 labeling of monoclonal antibodies and fragments with preservation of immunoreactivity. , 1991, Bioconjugate chemistry.

[30]  John Calvin Reed,et al.  Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[31]  C. Dence,et al.  Fluorine-18 labeling of proteins. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.